Jean-Philippe Collet

Showing 1-10 of 10 articles

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy

Overtchouk P, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet J, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G

February 5, 2021 | 10.4244/EIJ-D-20-00139

Coronary interventions

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: A CULPRIT-SHOCK angiographic substudy

Overtchouk P, Barthelemy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet J, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G, Bertin B, Brugier D, Vignolles N, Hage G, El Kasty M, Kerneis M, Huber K, Sandri M, Noc M, Fuernau G

July 7, 2020 | 10.4244/EIJ-D-20-00139

Coronary interventions

Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis

Collet J, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm C, van’t Hof A, Montalescot G

September 20, 2018 | 10.4244/EIJ-D-18-00182

STEMI

The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis

Bellemain-Appaix A, Begue C, Bhatt D, Ducci K, Harrington R, Roe M, Wiviott SD, Cucherat M, Silvain J, Collet J, Bernasconi F, Montalescot G

May 20, 2018 | 10.4244/EIJ-D-17-00852

Interventions for heart failure

Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support

Overtchouk P, Pascal J, Lebreton G, Hulot J-S, Luyt C-E, Combes A, Kerneis M, Silvain J, Barthelemy O, Leprince P, Brechot N, Montalescot G, Collet J

April 6, 2018 | 10.4244/EIJ-D-17-01014

Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures

Guedeney P, Hammoudi N, Duthoit G, Yan Y, Silvain J, Pousset F, Isnard R, Redheuil A, Kerneis M, Collet J, Montalescot G

November 20, 2017 | 10.4244/EIJ-D-17-00518

Interventions for valvular disease

Antithrombotic therapy in TAVI patients: changing concepts

Gargiulo G, Collet J, Valgimigli M

September 17, 2015 | 10.4244/EIJV11SWA28

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

Capodanno D, Lip G, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet J, Valgimigli M, Byrne R

January 22, 2015 | 10.4244/EIJV10I9A174

2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S, Kolh P, Alfonso F, Collet J, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Jüni P, Kappetein A, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F, Richter D, Schauerte P, Uva M, Stefanini G, Taggart D, Torracca L, Valgimigli M, Wijns W, Witkowski A

January 22, 2015 | 10.4244/EIJY14M09_01

Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?

Collet J, Montalescot G

September 15, 2013 | 10.4244/EIJV9SSA9

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers